Patent References 3336192 3746490 Pharmaceutical preparation for oral use Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-acid secretion related diseases Patent #: 5215974 InventorsAssigneeApplicationNo. 235258 filed on 04/29/1994US Classes:424/484, Matrices424/464, Tablets, lozenges, or pills424/471, Plural concentric cores424/472, Layered unitary dosage forms424/475, Organic coatings424/480, Cellulose or derivative424/482, Containing solid synthetic polymers424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/490, Coated (e.g., microcapsules)514/338, Plural hetero atoms in the polycyclo ring system514/360Plural ring chalcogens in the hetero ringExaminersPrimary: Levy, Neil S.Attorney, Agent or FirmForeign Patent References
International ClassA61K 009/16Foreign Application Priority Data1993-04-30 SEAbstractA stable, oral pharmaceutical composition comprising a proton pump inhibitor and a gelling agent designed for the treatment of gastric acid related diseases in animals, the process for preparation of the composition and the use thereof.Other References
Field of SearchCellulose or derivativeContaining natural gums or resins Containing solid synthetic polymers Organic coatings Plural concentric cores Layered unitary dosage forms Tablets, lozenges, or pills Matrices Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) Coated (e.g., microcapsules) Plural hetero atoms in the polycyclo ring system Plural ring chalcogens in the hetero ring | |